Nolan Lisa 4
4 · REXAHN PHARMACEUTICALS, INC. · Filed Jan 25, 2019
Insider Transaction Report
Form 4
Nolan Lisa
Chief Business Officer
Transactions
- Award
Stock Option (right to buy)
2019-01-25+130,000→ 130,000 totalExercise: $0.62Exp: 2029-01-25→ Common Stock (130,000 underlying)
Footnotes (1)
- [F1]One quarter of the option vests and becomes exercisable on January 25, 2020, and, thereafter, 1/36th of the remaining option vests in equal installments on each monthly anniversary of such date until fully vested.